CeloNova Announces Appointment of New President and CEO

August 6, 2019 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company and manufacturer of the proprietary Polyzene™-F nanocoating technology, currently used to surface coat its novel COBRA PzF NanoCoated Coronary Stent (NCS), today announced appointment of seasoned medical device executive Carl J. St. Bernard as President and Chief Executive Officer to support the company's expected near-term [...]

2019-08-07T15:42:00+00:00 August 6th, 2019|Comments Off on CeloNova Announces Appointment of New President and CEO